{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:55:09Z","timestamp":1786866909295,"version":"build-2736575974"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305740\/2019-9"],"award-info":[{"award-number":["305740\/2019-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309431\/2022-0"],"award-info":[{"award-number":["309431\/2022-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308220\/2021-8"],"award-info":[{"award-number":["308220\/2021-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006182","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Esp\u00edrito Santo","doi-asserted-by":"publisher","award":["Edital 15\/2022 - PROFIX: 708\/2022"],"award-info":[{"award-number":["Edital 15\/2022 - PROFIX: 708\/2022"]}],"id":[{"id":"10.13039\/501100006182","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006182","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Esp\u00edrito Santo","doi-asserted-by":"publisher","award":["Edital 15\/2022 - PROFIX: 630\/2022"],"award-info":[{"award-number":["Edital 15\/2022 - PROFIX: 630\/2022"]}],"id":[{"id":"10.13039\/501100006182","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s43440-025-00724-7","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T06:24:54Z","timestamp":1744352694000},"page":"645-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Probiotics: a promising future in the treatment of ulcerative colitis?"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-8419","authenticated-orcid":false,"given":"Larissa Zambom","family":"C\u00f4co","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6376-0096","authenticated-orcid":false,"given":"Eduarda","family":"de Souza Belis\u00e1rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-7454","authenticated-orcid":false,"given":"Elisardo Corral","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4053-5061","authenticated-orcid":false,"given":"Thiago Melo Costa","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9532-9401","authenticated-orcid":false,"given":"Rafaela","family":"Aires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-4892","authenticated-orcid":false,"given":"Bianca Prandi","family":"Campagnaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"10080","key":"724_CR1","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"29","author":"R Ungaro","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;29(10080):1756\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(16)32126-2.","journal-title":"Lancet"},{"issue":"12","key":"724_CR2","doi-asserted-by":"publisher","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","volume":"65","author":"M Gajendran","year":"2019","unstructured":"Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis. Dis Mon. 2019;65(12):100851. https:\/\/doi.org\/10.1016\/j.disamonth.2019.02.004.","journal-title":"Dis Mon"},{"key":"724_CR3","doi-asserted-by":"publisher","first-page":"175628482211381","DOI":"10.1177\/17562848221138160","volume":"29","author":"N Aslam","year":"2022","unstructured":"Aslam N, Lo SW, Sikafi R, Barnes T, Segal J, Smith PJ, et al. A review of the therapeutic management of ulcerative colitis. Th Adv Gastroenterol. 2022;29:15:17562848221138160. https:\/\/doi.org\/10.1177\/17562848221138160.","journal-title":"Th Adv Gastroenterol"},{"key":"724_CR4","doi-asserted-by":"publisher","first-page":"1216674","DOI":"10.3389\/fmicb.2023.1216674","volume":"17","author":"A Latif","year":"2023","unstructured":"Latif A, Shehzad A, Niazi S, Zahid A, Ashraf W, Iqbal MW, et al. Probiotics: mechanism of action, health benefits and their application in food industries. Front Microbiol. 2023;17:14:1216674. https:\/\/doi.org\/10.3389\/fmicb.2023.1216674.","journal-title":"Front Microbiol"},{"issue":"3","key":"724_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5507\/bp.2016.044","volume":"160","author":"VD Palumbo","year":"2016","unstructured":"Palumbo VD, Romeo M, Marino Gammazza A, Carini F, Damiani P, Damiano G, et al. The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160(3):372\u20137. https:\/\/doi.org\/10.5507\/bp.2016.044.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"724_CR6","doi-asserted-by":"publisher","first-page":"575173","DOI":"10.3389\/fimmu.2020.575173","volume":"11","author":"P Yu","year":"2020","unstructured":"Yu P, Ke C, Guo J, Zhang X, Li B. Lactobacillus plantarum L15 alleviates colitis by inhibiting LPS-mediated NF-\u03baB activation and ameliorates DSS-induced gut microbiota dysbiosis. Front Immunol. 2020;11:575173. https:\/\/doi.org\/10.3389\/fimmu.2020.575173.","journal-title":"Front Immunol"},{"issue":"1","key":"724_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00253-019-10259-6","volume":"104","author":"Y Wang","year":"2020","unstructured":"Wang Y, Xie Q, Zhang Y, Ma W, Ning K, Xiang JY, et al. Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function. Appl Microbiol Biotechnol. 2020;104(1):335\u201349. https:\/\/doi.org\/10.1007\/s00253-019-10259-6.","journal-title":"Appl Microbiol Biotechnol"},{"key":"724_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mib.2020.08.003","volume":"56","author":"Y Yang","year":"2020","unstructured":"Yang Y, Palm NW. Immunoglobulin A and the Microbiome. Curr Opin Microbiol. 2020;56:89\u201396. https:\/\/doi.org\/10.1016\/j.mib.2020.08.003.","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"724_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/jcm11020400","volume":"13","author":"A Ka\u0142u\u017cna","year":"2022","unstructured":"Ka\u0142u\u017cna A, Olczyk P, Komosi\u0144ska-Vassev K. The role of innate and adaptive immune cells in the pathogenesis and development of the inflammatory response in ulcerative colitis. J Clin Med. 2022;13(2):400. https:\/\/doi.org\/10.3390\/jcm11020400.","journal-title":"J Clin Med"},{"issue":"4","key":"724_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s12276-023-00960-y","volume":"55","author":"C Song","year":"2023","unstructured":"Song C, Chai Z, Chen S, Zhang H, Zhang X, Zhou Y. Intestinal mucus components and secretion mechanisms: what we do and do not know. Exp Mol Med. 2023;55(4):681\u201391. https:\/\/doi.org\/10.1038\/s12276-023-00960-y.","journal-title":"Exp Mol Med"},{"issue":"4\u20135","key":"724_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/08820131003622635","volume":"39","author":"NJ Mantis","year":"2010","unstructured":"Mantis NJ, Forbes SJ. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest. 2010;39(4\u20135):383\u2013406. https:\/\/doi.org\/10.3109\/08820131003622635.","journal-title":"Immunol Invest"},{"issue":"3","key":"724_CR12","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/ismej.2014.165","volume":"9","author":"H Zhang","year":"2015","unstructured":"Zhang H, Sparks JB, Karyala SV, Settlage R, Luo XM. Host adaptive immunity alters gut microbiota. ISME J. 2015;9(3):770\u201381. https:\/\/doi.org\/10.1038\/ismej.2014.165.","journal-title":"ISME J"},{"issue":"3","key":"724_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/19490976.2019.1626683","volume":"3","author":"S Rengarajan","year":"2020","unstructured":"Rengarajan S, Vivio EE, Parkes M, Peterson DA, Roberson EDO, Newberry RD, et al. Dynamic Immunoglobulin responses to gut bacteria during inflammatory bowel disease. Gut Microbes. 2020;3(3):405\u201320. https:\/\/doi.org\/10.1080\/19490976.2019.1626683.","journal-title":"Gut Microbes"},{"issue":"43","key":"724_CR14","doi-asserted-by":"publisher","first-page":"7402","DOI":"10.3748\/wjg.v27.i43.7402","volume":"21","author":"J Gubatan","year":"2021","unstructured":"Gubatan J, Holman DR, Puntasecca CJ, Polevoi D, Rubin SJ, Rogalla S. Antimicrobial peptides and the gut Microbiome in inflammatory bowel disease. World J Gastroenterol. 2021;21(43):7402\u201322. https:\/\/doi.org\/10.3748\/wjg.v27.i43.7402.","journal-title":"World J Gastroenterol"},{"key":"724_CR15","doi-asserted-by":"publisher","first-page":"113189","DOI":"10.1016\/j.biopha.2022.113189","volume":"151","author":"PN Dlozi","year":"2022","unstructured":"Dlozi PN, Gladchuk A, Crutchley RD, Keuler N, Coetzee R, Dube A. Cathelicidins and defensins antimicrobial host defense peptides in the treatment of TB and HIV: Pharmacogenomic and nanomedicine approaches towards improved therapeutic outcomes. Biomed Pharmacother. 2022;151:113189. https:\/\/doi.org\/10.1016\/j.biopha.2022.113189.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"724_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00042737-200606000-00007","volume":"18","author":"J Schauber","year":"2006","unstructured":"Schauber J, Rieger D, Weiler F, Wehkamp J, Eck M, Fellermann K, et al. Heter;ogeneous expression of human Cathelicidin hCAP18\/LL-37 in inflammatory bowel diseases. Eur J Gastroenterol Hepatol. 2006;18(6):615\u201321. https:\/\/doi.org\/10.1097\/00042737-200606000-00007.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"724_CR17","doi-asserted-by":"publisher","first-page":"e0051921","DOI":"10.1128\/Spectrum.00519-21","volume":"31","author":"CE Nelson","year":"2021","unstructured":"Nelson CE, Huang W, Zygiel EM, Nolan EM, Kane MA, Oglesby AG. The human innate immune protein calprotectin elicits a multimetal starvation response in Pseudomonas aeruginosa. Microbiol Spectr. 2021;31(2):e0051921. https:\/\/doi.org\/10.1128\/Spectrum.00519-21.","journal-title":"Microbiol Spectr"},{"key":"724_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-food-061120-014739","volume":"25","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zhai Q, Zhang H, Chen W, Hill C. Gut colonization mechanisms of Lactobacillus and Bifidobacterium: an argument for personalized designs. Annu Rev Food Sci Technol. 2021;25:12:213\u201333. https:\/\/doi.org\/10.1146\/annurev-food-061120-014739.","journal-title":"Annu Rev Food Sci Technol"},{"key":"724_CR19","doi-asserted-by":"publisher","first-page":"583919","DOI":"10.3389\/fcell.2020.583919","volume":"12","author":"WD Rees","year":"2020","unstructured":"Rees WD, Tandun R, Yau E, Zachos NC, Steiner TS. Regenerative intestinal stem cells induced by acute and chronic injury: the saving grace of the epithelium? Front Cell Dev Biol. 2020;12:8:583919. https:\/\/doi.org\/10.3389\/fcell.2020.583919.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"724_CR20","doi-asserted-by":"publisher","first-page":"e13357","DOI":"10.1111\/asj.13357","volume":"91","author":"T Suzuki","year":"2020","unstructured":"Suzuki T. Regulation of the intestinal barrier by nutrients: the role of tight junctions. Anim Sci J. 2020;91(1):e13357. https:\/\/doi.org\/10.1111\/asj.13357.","journal-title":"Anim Sci J"},{"issue":"2","key":"724_CR21","doi-asserted-by":"publisher","first-page":"2077620","DOI":"10.1080\/21688370.2022.2077620","volume":"3","author":"A Moonwiriyakit","year":"2023","unstructured":"Moonwiriyakit A, Pathomthongtaweechai N, Steinhagen PR, Chantawichitwong P, Satianrapapong W, Pongkorpsakol P. Tight junctions: from molecules to Gastrointestinal diseases. Tissue Barriers. 2023;3(2):2077620. https:\/\/doi.org\/10.1080\/21688370.2022.2077620.","journal-title":"Tissue Barriers"},{"issue":"4","key":"724_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12272-021-01327-5","volume":"44","author":"K Seo","year":"2021","unstructured":"Seo K, Seo J, Yeun J, Choi H, Kim YI, Chang SY. The role of mucosal barriers in human gut health. Arch Pharm Res. 2021;44(4):325\u201341. https:\/\/doi.org\/10.1007\/s12272-021-01327-5.","journal-title":"Arch Pharm Res"},{"key":"724_CR23","doi-asserted-by":"publisher","first-page":"431231","DOI":"10.1155\/2013\/431231","volume":"2013","author":"AE Dorofeyev","year":"2013","unstructured":"Dorofeyev AE, Vasilenko IV, Rassokhina OA, Kondratiuk RB. Mucosal barrier in ulcerative colitis and Crohn\u2019s disease. Gastroenterol Res Pract. 2013:431231. https:\/\/doi.org\/10.1155\/2013\/431231.","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"724_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.sempedsurg.2017.10.003","volume":"26","author":"YR Yu","year":"2017","unstructured":"Yu YR, Rodriguez JR. Clinical presentation of Crohn\u2019s, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Semin Pediatr Surg. 2017;26(6):349\u201355. https:\/\/doi.org\/10.1053\/j.sempedsurg.2017.10.003.","journal-title":"Semin Pediatr Surg"},{"issue":"4","key":"724_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du L, Ha C. Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am. 2020;49(4):643\u201354. https:\/\/doi.org\/10.1016\/j.gtc.2020.07.005.","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"724_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1590\/s0004-28032009000100009","volume":"46","author":"CR Victoria","year":"2009","unstructured":"Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in Midwestern of S\u00e3o Paulo State, Brazil. Arq Gastroenterol. 2009;46(1):20\u20135. https:\/\/doi.org\/10.1590\/s0004-28032009000100009.","journal-title":"Arq Gastroenterol"},{"issue":"12","key":"724_CR27","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3390\/genes13122388","volume":"16","author":"S Jarmakiewicz-Czaja","year":"2022","unstructured":"Jarmakiewicz-Czaja S, Zieli\u0144ska M, Sokal A, Filip R. Genetic and epigenetic etiology of inflammatory bowel disease: an update. Genes (Basel). 2022;16(12):2388. https:\/\/doi.org\/10.3390\/genes13122388.","journal-title":"Genes (Basel)"},{"issue":"27","key":"724_CR28","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.3748\/wjg.v22.i27.6296","volume":"21","author":"AT Abegunde","year":"2016","unstructured":"Abegunde AT, Muhammad BH, Bhatti O, Ali T. Environmental risk factors for inflammatory bowel diseases: evidence based literature review. World J Gastroenterol. 2016;21(27):6296\u2013317. https:\/\/doi.org\/10.3748\/wjg.v22.i27.6296.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"724_CR29","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.ijsu.2013.08.019","volume":"11","author":"J Ahmed","year":"2013","unstructured":"Ahmed J, Reddy BS, M\u00f8lbak L, Leser TD, MacFie J. Impact of probiotics on colonic microflora in patients with colitis: a prospective double blind randomised crossover study. Int J Surg. 2013;11(10):1131\u20136. https:\/\/doi.org\/10.1016\/j.ijsu.2013.08.019.","journal-title":"Int J Surg"},{"issue":"1","key":"724_CR30","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/s41598-021-81628-3","volume":"25","author":"O Zakerska-Banaszak","year":"2021","unstructured":"Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, et al. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study. Sci Rep. 2021;25(1):2166. https:\/\/doi.org\/10.1038\/s41598-021-81628-3.","journal-title":"Sci Rep"},{"issue":"5","key":"724_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ibd.21866","volume":"18","author":"NA Nagalingam","year":"2012","unstructured":"Nagalingam NA, Lynch SV. Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2012;18(5):968\u201384. https:\/\/doi.org\/10.1002\/ibd.21866.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"724_CR32","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1751-2980.12849","volume":"21","author":"XY Guo","year":"2020","unstructured":"Guo XY, Liu XJ, Hao JY. Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment. J Dig Dis. 2020;21(3):147\u201359. https:\/\/doi.org\/10.1111\/1751-2980.12849.","journal-title":"J Dig Dis"},{"key":"724_CR33","doi-asserted-by":"publisher","first-page":"953962","DOI":"10.3389\/fcimb.2022.953962","volume":"30","author":"S Zhu","year":"2022","unstructured":"Zhu S, Han M, Liu S, Fan L, Shi H, Li P. Composition and diverse differences of intestinal microbiota in ulcerative colitis patients. Front Cell Infect Microbiol. 2022;30(12):953962. https:\/\/doi.org\/10.3389\/fcimb.2022.953962.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"724_CR34","doi-asserted-by":"publisher","first-page":"101726","DOI":"10.1016\/j.jksus.2021.101726","volume":"34","author":"RS Alharbi","year":"2022","unstructured":"Alharbi RS, Shaik NA, Almahdi H, ElSokary HA, Jamalalail BA, Mosli MH, et al. Genetic association study of NOD2 and IL23R amino acid substitution polymorphisms in Saudi inflammatory bowel disease patients. J King Saud Univ Sci. 2022;34(1):101726. https:\/\/doi.org\/10.1016\/j.jksus.2021.101726.","journal-title":"J King Saud Univ Sci"},{"key":"724_CR35","doi-asserted-by":"publisher","first-page":"1302886","DOI":"10.3389\/fgene.2023.1302886","volume":"14","author":"L Yan","year":"2023","unstructured":"Yan L, Gu C, Gao S, Wei B. Epigenetic regulation and therapeutic strategies in ulcerative colitis. Front Genet. 2023;14:1302886. https:\/\/doi.org\/10.3389\/fgene.2023.1302886.","journal-title":"Front Genet"},{"issue":"6","key":"724_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/imj.13094","volume":"46","author":"O Niewiadomski","year":"2016","unstructured":"Niewiadomski O, Studd C, Wilson J, Williams J, Hair C, Knight R, et al. Influence of food and lifestyle on the risk of developing inflammatory bowel disease. Intern Med. 2016;46(6):669\u201376. https:\/\/doi.org\/10.1111\/imj.13094.","journal-title":"Intern Med"},{"issue":"6","key":"724_CR37","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1111\/j.1365-2672.2007.03497.x","volume":"103","author":"R Mart\u00edn","year":"2007","unstructured":"Mart\u00edn R, Heilig GH, Zoetendal EG, Smidt H, Rodr\u00edguez JM. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol. 2007;103(6):2638\u201344. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03497.x.","journal-title":"J Appl Microbiol"},{"issue":"9","key":"724_CR38","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/apt.14291","volume":"46","author":"L Xu","year":"2017","unstructured":"Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN. Systematic review with meta-analysis: breastfeeding and the risk of Crohn\u2019s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780\u20139. https:\/\/doi.org\/10.1111\/apt.14291.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"724_CR39","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/ajg.2010.398","volume":"105","author":"SY Shaw","year":"2010","unstructured":"Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105(12):2687\u201392. https:\/\/doi.org\/10.1038\/ajg.2010.398.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"724_CR40","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/ajg.2011.44","volume":"106","author":"JK Hou","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563\u201373. https:\/\/doi.org\/10.1038\/ajg.2011.44.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"724_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.chom.2019.06.013","volume":"14","author":"JE Bisanz","year":"2019","unstructured":"Bisanz JE, Upadhyay V, Turnbaugh JA, Ly K, Turnbaugh PJ. Meta-Analysis reveals reproducible gut Microbiome alterations in response to a High-Fat diet. Cell Host Microbe. 2019;14(2):265\u2013e2724. https:\/\/doi.org\/10.1016\/j.chom.2019.06.013.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"724_CR42","first-page":"367","volume":"9","author":"AN Ananthakrishnan","year":"2013","unstructured":"Ananthakrishnan AN. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;9(6):367\u201374.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"724_CR43","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fmicb.2018.02247","volume":"25","author":"T Zuo","year":"2018","unstructured":"Zuo T, Ng SC. The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease. Front Microbiol. 2018;25:9:2247. https:\/\/doi.org\/10.3389\/fmicb.2018.02247.","journal-title":"Front Microbiol"},{"key":"724_CR44","doi-asserted-by":"publisher","first-page":"1103617","DOI":"10.3389\/fimmu.2023.1103617","volume":"16","author":"M Zhang","year":"2023","unstructured":"Zhang M, Li X, Zhang Q, Yang J, Liu G. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Front Immunol. 2023;16:14:1103617. https:\/\/doi.org\/10.3389\/fimmu.2023.1103617.","journal-title":"Front Immunol"},{"key":"724_CR45","doi-asserted-by":"publisher","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","volume":"9","author":"L Chen","year":"2023","unstructured":"Chen L, Ruan G, Cheng Y, Yi A, Chen D, Wei Y. The role of Th17 cells in inflammatory bowel disease and the research progress. Front Immunol. 2023;9:13:1055914. https:\/\/doi.org\/10.3389\/fimmu.2022.1055914.","journal-title":"Front Immunol"},{"issue":"6","key":"724_CR46","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mi.2017.21","volume":"10","author":"A Harusato","year":"2017","unstructured":"Harusato A, Abo H, Ngo VL, Yi SW, Mitsutake K, Osuka S, et al. IL-36\u03b3 signaling controls the induced regulatory T cell-Th9 cell balance via NF\u03baB activation and STAT transcription factors. Mucosal Immunol. 2017;10(6):1455\u201367. https:\/\/doi.org\/10.1038\/mi.2017.21.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"724_CR47","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1053\/j.gastro.2018.11.029","volume":"156","author":"K Scheibe","year":"2019","unstructured":"Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carl\u00e9 B, et al. Inhibiting Interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation. Gastroenterology. 2019;156(4):1082\u2013e109711. https:\/\/doi.org\/10.1053\/j.gastro.2018.11.029.","journal-title":"Gastroenterology"},{"issue":"9853","key":"724_CR48","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"3","author":"I Ord\u00e1s","year":"2012","unstructured":"Ord\u00e1s I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;3(9853):1606\u201319. https:\/\/doi.org\/10.1016\/S0140-6736(12)60150-0.","journal-title":"Lancet"},{"issue":"1","key":"724_CR49","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"10","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis. Nat Rev Dis Primers. 2020;10(1):74. https:\/\/doi.org\/10.1038\/s41572-020-0205-x.","journal-title":"Nat Rev Dis Primers"},{"key":"724_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.redox.2015.07.013","volume":"6","author":"M Al-Salihi","year":"2015","unstructured":"Al-Salihi M, Reichert E, Fitzpatrick FA. Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of Apc(Min\/+) mice. Redox Biol. 2015;6:218\u201325. https:\/\/doi.org\/10.1016\/j.redox.2015.07.013.","journal-title":"Redox Biol"},{"key":"724_CR51","doi-asserted-by":"publisher","unstructured":"Tian T, Wang Z, Zhang J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxid Med Cell Longev. 2017;4535194. https:\/\/doi.org\/10.1155\/2017\/4535194.","DOI":"10.1155\/2017\/4535194"},{"issue":"6","key":"724_CR52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0003-4509(06)75333-0","volume":"64","author":"P Therond","year":"2006","unstructured":"Therond P. Dommages Cr\u00e9\u00e9s aux biomol\u00e9cules (lipides, Prot\u00e9ines, ADN) par Le stress oxydant [Oxidative stress and damages to biomolecules (lipids, proteins, DNA)]. Ann Pharm Fr. 2006;64(6):383\u20139. https:\/\/doi.org\/10.1016\/s0003-4509(06)75333-0.","journal-title":"Ann Pharm Fr"},{"key":"724_CR53","doi-asserted-by":"publisher","unstructured":"Wang Z, Li S, Cao Y, Tian X, Zeng R, Liao DF, et al. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid Med Cell Longev. 2016;9875298. https:\/\/doi.org\/10.1155\/2016\/9875298.","DOI":"10.1155\/2016\/9875298"},{"issue":"11","key":"724_CR54","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.molmed.2020.06.006","volume":"26","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, Feelisch M, Faber KN, Pasch A, Dijkstra G, van Goor H. Oxidative stress and Redox-Modulating therapeutics in inflammatory bowel disease. Trends Mol Med. 2020;26(11):1034\u201346. https:\/\/doi.org\/10.1016\/j.molmed.2020.06.006.","journal-title":"Trends Mol Med"},{"issue":"2","key":"724_CR55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","volume":"160","author":"M Lee","year":"2021","unstructured":"Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the Microbiome-Searching the crime scene for clues. Gastroenterology. 2021;160(2):524\u201337. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.056.","journal-title":"Gastroenterology"},{"issue":"7","key":"724_CR56","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/ijms23073464","volume":"23","author":"PT Santana","year":"2022","unstructured":"Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci. 2022;23(7):3464. https:\/\/doi.org\/10.3390\/ijms23073464.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"724_CR57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.pop.2017.07.010","volume":"44","author":"T Sairenji","year":"2017","unstructured":"Sairenji T, Collins KL, Evans DV. An update on inflammatory bowel disease. Prim Care. 2017;44(4):673\u201392. https:\/\/doi.org\/10.1016\/j.pop.2017.07.010.","journal-title":"Prim Care"},{"issue":"8","key":"724_CR58","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","volume":"95","author":"JB Felder","year":"2000","unstructured":"Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000;95(8):1949\u201354. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02262.x.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"724_CR59","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/00365521.2014.966753","volume":"50","author":"CL Kvasnovsky","year":"2015","unstructured":"Kvasnovsky CL, Aujla U, Bjarnason I. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(3):255\u201363. https:\/\/doi.org\/10.3109\/00365521.2014.966753.","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"724_CR60","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.14309\/ajg.0000000000001932","volume":"1","author":"S Cohen-Mekelburg","year":"2022","unstructured":"Cohen-Mekelburg S, Van T, Wallace B, Berinstein J, Yu X, Lewis J, et al. The association between nonsteroidal Anti-Inflammatory drug use and inflammatory bowel disease exacerbations: A true association or residual bias? Am J Gastroenterol. 2022;1(11):1851\u20137. https:\/\/doi.org\/10.14309\/ajg.0000000000001932.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"724_CR61","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/j.1572-0241.2000.02263","volume":"95","author":"GF Bonner","year":"2000","unstructured":"Bonner GF, Walczak M, Kitchen L, Bayona M. Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease. Am J Gastroenterol. 2000;95(8):1946\u20138. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02263.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"724_CR62","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608","volume":"97","author":"U Mahadevan","year":"2002","unstructured":"Mahadevan U, Loftus EV Jr, Tremaine WJ, Sandborn WJ. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am J Gastroenterol. 2002;97(4):910\u20134. https:\/\/doi.org\/10.1111\/j.1572-0241.2002.05608.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"724_CR63","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384","volume":"101","author":"Y El Miedany","year":"2006","unstructured":"El Miedany Y, Youssef S, Ahmed I, El Gaafary M. The Gastrointestinal safety and effect on disease activity of Etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol. 2006;101(2):311\u20137. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00384.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"724_CR64","doi-asserted-by":"publisher","first-page":"CD007744","DOI":"10.1002\/14651858.CD007744","volume":"23","author":"XP Miao","year":"2014","unstructured":"Miao XP, Li JS, Ouyang Q, Hu RW, Zhang Y, Li HY. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. Cochrane Database Syst Rev. 2014;23(10):CD007744. https:\/\/doi.org\/10.1002\/14651858.CD007744.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"724_CR65","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/apt.14606","volume":"47","author":"OO Moninuola","year":"2018","unstructured":"Moninuola OO, Milligan W, Lochhead P, Khalili H. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn\u2019s disease and ulcerative colitis exacerbation. Aliment Pharmacol Ther. 2018;47(11):1428\u201339. https:\/\/doi.org\/10.1111\/apt.14606.","journal-title":"Aliment Pharmacol Ther"},{"key":"724_CR66","doi-asserted-by":"crossref","unstructured":"Ribaldone DG, Fagoonee S, Astegiano M, De Angelis C, Smedile A, Caviglia GP et al. Coxib\u2019s Safety in Patients with Inflammatory Bowel Diseases: A Meta-analysis. Pain Physician. 2015;18(6):599\u2013607. Erratum in: Pain Physician. 2016;19(2):101.","DOI":"10.36076\/ppj.2015\/18\/599"},{"issue":"3","key":"724_CR67","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","volume":"156","author":"CW Ko","year":"2019","unstructured":"Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK, American Gastroenterological Association Institute Clinical Guidelines Committee. AGA clinical practice guidelines on the management of Mild-to-Moderate ulcerative colitis. Gastroenterology. 2019;156(3):748\u201364. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.009.","journal-title":"Gastroenterology"},{"issue":"1","key":"724_CR68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/jcm9010094","volume":"30","author":"M Kayal","year":"2019","unstructured":"Kayal M, Shah S. Ulcerative colitis: current and emerging treatment strategies. J Clin Med. 2019;30(1):94. https:\/\/doi.org\/10.3390\/jcm9010094.","journal-title":"J Clin Med"},{"issue":"2","key":"724_CR69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5114\/pg.2017.68166","volume":"12","author":"E Stawowczyk","year":"2017","unstructured":"Stawowczyk E, Kawalec P. Cost-effectiveness of biological treatment of ulcerative colitis - a systematic review. Prz Gastroenterol. 2017;12(2):90\u20137. https:\/\/doi.org\/10.5114\/pg.2017.68166.","journal-title":"Prz Gastroenterol"},{"issue":"5","key":"724_CR70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/1744666X.2022.2069562","volume":"18","author":"J Hanzel","year":"2022","unstructured":"Hanzel J, Hulshoff MS, Grootjans J, D\u2019Haens G. Emerging therapies for ulcerative colitis. Expert Rev Clin Immunol. 2022;18(5):513\u201324. https:\/\/doi.org\/10.1080\/1744666X.2022.2069562.","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"724_CR71","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/14712598.2020.1697227","volume":"20","author":"J Han\u017eel","year":"2020","unstructured":"Han\u017eel J, D\u2019Haens GR. Anti-interleukin-23 agents for the treatment of ulcerative colitis. Expert Opin Biol Ther. 2020;20(4):399\u2013406. https:\/\/doi.org\/10.1080\/14712598.2020.1697227.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"724_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00011-023-01829-6","volume":"73","author":"HA Suilik","year":"2024","unstructured":"Suilik HA, Jaber F, Abuelazm M, Ramadan A, Elzeftawy MA, Elrosasy A, et al. Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Inflamm Res. 2024;73(2):183\u201398. https:\/\/doi.org\/10.1007\/s00011-023-01829-6.","journal-title":"Inflamm Res"},{"issue":"23","key":"724_CR73","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.3390\/jcm13237186","volume":"27","author":"B Neri","year":"2024","unstructured":"Neri B, Mancone R, Fiorillo M, Schiavone SC, Migliozzi S, Biancone L. Efficacy and safety of Janus Kinase-Inhibitors in ulcerative colitis. J Clin Med. 2024;27(23):7186. https:\/\/doi.org\/10.3390\/jcm13237186.","journal-title":"J Clin Med"},{"issue":"11","key":"724_CR74","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2003.037747","volume":"53","author":"W Kruis","year":"2004","unstructured":"Kruis W, Fric P, Pokrotnieks J, Luk\u00e1s M, Fixa B, Kasc\u00e1k M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53(11):1617\u201323. https:\/\/doi.org\/10.1136\/gut.2003.037747.","journal-title":"Gut"},{"key":"724_CR75","doi-asserted-by":"publisher","unstructured":"Ton AMM, Campagnaro BP, Alves GA, Aires R, C\u00f4co LZ, Arpini CM, et al. Oxidative stress and dementia in Alzheimer\u2019s patients: effects of synbiotic supplementation. Oxid Med Cell Longev. 2020;2638703. https:\/\/doi.org\/10.1155\/2020\/2638703.","DOI":"10.1155\/2020\/2638703"},{"issue":"11","key":"724_CR76","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1080\/1028415X.2021.1970299","volume":"25","author":"VR Lemos","year":"2022","unstructured":"Lemos VR, Aires R, C\u00f4co LZ, Domingues RB, Meyrelles SS, Vasquez EC, et al. Benefits of multi-day supplementation with probiotic Kefir in Rasmussen encephalitis: the first case report. Nutr Neurosci. 2022;25(11):2390\u20137. https:\/\/doi.org\/10.1080\/1028415X.2021.1970299.","journal-title":"Nutr Neurosci"},{"key":"724_CR77","doi-asserted-by":"publisher","unstructured":"Reid G, Gadir AA, Dhir R, Probiotics. Reiterating What They Are and What They Are Not. Front Microbiol. 2019;12(10):424. https:\/\/doi.org\/10.3389\/fmicb.2019.00424","DOI":"10.3389\/fmicb.2019.00424"},{"issue":"Suppl1","key":"724_CR78","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/advances\/nmy063","volume":"10","author":"J Plaza-Diaz","year":"2019","unstructured":"Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019;10(Suppl1):S49\u201366. https:\/\/doi.org\/10.1093\/advances\/nmy063.","journal-title":"Adv Nutr"},{"issue":"3","key":"724_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5152\/tjg.2018.18227","volume":"30","author":"\u0130 Y\u0131lmaz","year":"2019","unstructured":"Y\u0131lmaz \u0130, Dolar ME, \u00d6zp\u0131nar H. Effect of administering Kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: a randomized controlled trial. Turk J Gastroenterol. 2019;30(3):242\u201353. https:\/\/doi.org\/10.5152\/tjg.2018.18227.","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"724_CR80","doi-asserted-by":"publisher","first-page":"e0165122","DOI":"10.1128\/spectrum.01651-22","volume":"10","author":"Y Wu","year":"2022","unstructured":"Wu Y, Jha R, Li A, Liu H, Zhang Z, Zhang, et al. Probiotics (Lactobacillus Kruis plantarum HNU082) supplementation relieves ulcerative colitis by affecting intestinal barrier functions, immunity-related gene expression, gut microbiota, and metabolic pathways in mice. Microbiol Spectr. 2022;10(6):e0165122. https:\/\/doi.org\/10.1128\/spectrum.01651-22.","journal-title":"Microbiol Spectr"},{"issue":"24","key":"724_CR81","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.3390\/cells12242799","volume":"12","author":"LZ C\u00f4co","year":"2023","unstructured":"C\u00f4co LZ, Aires R, Carvalho GR, Belis\u00e1rio ES, Yap MKK, Amorim FG, et al. Unravelling the gastroprotective potential of Kefir: exploring antioxidant effects in preventing gastric ulcers. Cells. 2023;12(24):2799. https:\/\/doi.org\/10.3390\/cells12242799.","journal-title":"Cells"},{"issue":"4","key":"724_CR82","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1039\/d1fo01798e","volume":"13","author":"R Aires","year":"2022","unstructured":"Aires R, Gobbi Amorim F, C\u00f4co LZ, da Concei\u00e7\u00e3o AP, Zanardo T\u00c9C, Taufner GH, et al. Use of Kefir peptide (Kef-1) as an emerging approach for the treatment of oxidative stress and inflammation in 2K1C mice. Food Funct. 2022;13(4):1965\u201374. https:\/\/doi.org\/10.1039\/d1fo01798e.","journal-title":"Food Funct"},{"issue":"3","key":"724_CR83","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/biomedicines11030865","volume":"11","author":"A Fusco","year":"2023","unstructured":"Fusco A, Savio V, Cimini D, D\u2019Ambrosio S, Chiaromonte A, Schiraldi C, et al. In vitro evaluation of the most active probiotic strains able to improve the intestinal barrier functions and to prevent inflammatory diseases of the Gastrointestinal system. Biomedicines. 2023;11(3):865. https:\/\/doi.org\/10.3390\/biomedicines11030865.","journal-title":"Biomedicines"},{"key":"724_CR84","doi-asserted-by":"publisher","first-page":"1137701","DOI":"10.3389\/fmicb.2023.1137701","volume":"14","author":"Q Liu","year":"2023","unstructured":"Liu Q, Jian W, Wang L, Yang S, Niu Y, Xie S, et al. Alleviation of DSS-induced colitis in mice by a new-isolated Lactobacillus acidophilus C4. Front Microbiol. 2023;14:1137701. https:\/\/doi.org\/10.3389\/fmicb.2023.1137701.","journal-title":"Front Microbiol"},{"issue":"1","key":"724_CR85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1756283X12459294","volume":"6","author":"P Hemarajata","year":"2013","unstructured":"Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal Immunomodulation and neuromodulation. Th Adv Gastroenterol. 2013;6(1):39\u201351. https:\/\/doi.org\/10.1177\/1756283X12459294.","journal-title":"Th Adv Gastroenterol"},{"issue":"6","key":"724_CR86","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1111\/1751-7915.13661","volume":"13","author":"P Chen","year":"2020","unstructured":"Chen P, Xu H, Tang H, Zhao F, Yang C, Kwok LY, et al. Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis. Microb Biotechnol. 2020;13(6):2032\u201343. https:\/\/doi.org\/10.1111\/1751-7915.13661.","journal-title":"Microb Biotechnol"},{"key":"724_CR87","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcimb.2015.00026","volume":"25","author":"Q Yu","year":"2015","unstructured":"Yu Q, Yuan L, Deng J, Yang Q. Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front Cell Infect Microbiol. 2015;25:5:26. https:\/\/doi.org\/10.3389\/fcimb.2015.00026.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"724_CR88","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.1038\/s41598-019-41738-5","volume":"1","author":"R Mart\u00edn","year":"2019","unstructured":"Mart\u00edn R, Chamignon C, Mhedbi-Hajri N, Chain F, Derrien M, et al. The potential probiotic Lactobacillus rhamnosus CNCM I-3690 strain protects the intestinal barrier by stimulating both mucus production and cytoprotective response. Sci Rep. 2019;1(1):5398. https:\/\/doi.org\/10.1038\/s41598-019-41738-5.","journal-title":"Sci Rep"},{"issue":"5","key":"724_CR89","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ajpath.2021.02.003","volume":"191","author":"R Al-Sadi","year":"2021","unstructured":"Al-Sadi R, Nighot P, Nighot M, Haque M, Rawat M, Ma TY. Lactobacillus acidophilus induces a strain-specific and toll-like receptor 2-dependent enhancement of intestinal epithelial tight junction barrier and protection against intestinal inflammation. Am J Pathol. 2021;191(5):872\u201384. https:\/\/doi.org\/10.1016\/j.ajpath.2021.02.003.","journal-title":"Am J Pathol"},{"key":"724_CR90","doi-asserted-by":"publisher","first-page":"851140","DOI":"10.3389\/fcimb.2022.851140","volume":"16","author":"TSK Anjana","year":"2022","unstructured":"Anjana TSK. Bacteriocin-producing probiotic lactic acid bacteria in controlling dysbiosis of the gut microbiota front. Cell Infect Microbiol. 2022;16:12:851140. https:\/\/doi.org\/10.3389\/fcimb.2022.851140.","journal-title":"Cell Infect Microbiol"},{"issue":"10","key":"724_CR91","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1039\/d3fo04706g","volume":"20","author":"B Xu","year":"2024","unstructured":"Xu B, Wang Z, Wang Y, Zhang K, Li J, Zhou L, et al. Milk-derived Lactobacillus with high production of short-chain fatty acids relieves antibiotic-induced diarrhea in mice. Food Funct. 2024;20(10):5329\u201342. https:\/\/doi.org\/10.1039\/d3fo04706g.","journal-title":"Food Funct"},{"issue":"9","key":"724_CR92","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.3390\/molecules25092088","volume":"29","author":"B Sulijaya","year":"2020","unstructured":"Sulijaya B, Takahashi N, Yamazaki K. Lactobacillus-derived bioactive metabolites for the regulation of periodontal health: evidences to clinical setting. Molecules. 2020;29(9):2088. https:\/\/doi.org\/10.3390\/molecules25092088.","journal-title":"Molecules"},{"key":"724_CR93","doi-asserted-by":"publisher","first-page":"1042189","DOI":"10.3389\/fphar.2022.1042189","volume":"24","author":"S Rastogi","year":"2022","unstructured":"Rastogi S, Singh A. Gut Microbiome and human health: exploring how the probiotic genus Lactobacillus modulates immune responses. Front Pharmacol. 2022;24:13:1042189. https:\/\/doi.org\/10.3389\/fphar.2022.1042189.","journal-title":"Front Pharmacol"},{"issue":"9","key":"724_CR94","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","volume":"22","author":"MA Vinolo","year":"2011","unstructured":"Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of Proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22(9):849\u201355. https:\/\/doi.org\/10.1016\/j.jnutbio.2010.07.009.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"724_CR95","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/nu3100858","volume":"3","author":"MA Vinolo","year":"2011","unstructured":"Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short-chain fatty acids. Nutrients. 2011;3(10):858\u201376. https:\/\/doi.org\/10.3390\/nu3100858.","journal-title":"Nutrients"},{"issue":"2","key":"724_CR96","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/BJ20082222","volume":"13","author":"N Burger-van Paassen","year":"2009","unstructured":"Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J. 2009;13(2):211\u20139. https:\/\/doi.org\/10.1042\/BJ20082222.","journal-title":"Biochem J"},{"issue":"6","key":"724_CR97","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3390\/ijms22063061","volume":"17","author":"N Gasaly","year":"2021","unstructured":"Gasaly N, Hermoso MA, Gotteland M. Butyrate and the fine-tuning of colonic homeostasis: implication for inflammatory bowel diseases. Int J Mol Sci. 2021;17(6):3061. https:\/\/doi.org\/10.3390\/ijms22063061.","journal-title":"Int J Mol Sci"},{"issue":"22","key":"724_CR98","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.3748\/wjg.v19.i22.3404","volume":"14","author":"R Kumari","year":"2013","unstructured":"Kumari R, Ahuja V, Paul J. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol. 2013;14(22):3404\u201314. https:\/\/doi.org\/10.3748\/wjg.v19.i22.3404.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"724_CR99","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12876-022-02191-3","volume":"10","author":"HM Xu","year":"2022","unstructured":"Xu HM, Zhao HL, Guo GJ, Xu J, Zhou YL, Huang HL, et al. Characterization of short-chain fatty acids in patients with ulcerative colitis: a meta-analysis. BMC Gastroenterol. 2022;10(1):117. https:\/\/doi.org\/10.1186\/s12876-022-02191-3.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"724_CR100","doi-asserted-by":"publisher","first-page":"e12707","DOI":"10.1016\/j.heliyon.2022.e12707","volume":"29","author":"K Nascimento da Silva","year":"2022","unstructured":"Nascimento da Silva K, F\u00e1vero AG, Ribeiro W, Ferreira CM, Sartorelli P, Cardili L, et al. Effects of Kefir fermented milk beverage on sodium dextran sulfate (DSS)-induced colitis in rats. Heliyon. 2022;29(1):e12707. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12707.","journal-title":"Heliyon"},{"issue":"11","key":"724_CR101","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","volume":"21","author":"J Landy","year":"2016","unstructured":"Landy J, Ronde E, English N, Clark SK, Hart AL, Knight SC, et al. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol. 2016;21(11):3117\u201326. https:\/\/doi.org\/10.3748\/wjg.v22.i11.3117.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"724_CR102","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/ibd\/izz328","volume":"18","author":"G Katinios","year":"2020","unstructured":"Katinios G, Casado-Bedmar M, Walter SA, Vicario M, Gonz\u00e1lez-Castro AM, Bednarska O, et al. Increased colonic epithelial permeability and mucosal eosinophilia in ulcerative colitis in remission compared with irritable bowel syndrome and health. Inflamm Bowel Dis. 2020;18(7):974\u201384. https:\/\/doi.org\/10.1093\/ibd\/izz328.","journal-title":"Inflamm Bowel Dis"},{"key":"724_CR103","doi-asserted-by":"publisher","first-page":"1143548","DOI":"10.3389\/fimmu.2023.1143548","volume":"24","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhang Z, Tang P, Wu Y, Zhang A, Li D, et al. Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials. Front Immunol. 2023;24:14:1143548. https:\/\/doi.org\/10.3389\/fimmu.2023.1143548.","journal-title":"Front Immunol"},{"issue":"6","key":"724_CR104","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1053\/gast.2001.29694","volume":"121","author":"AH Gitter","year":"2001","unstructured":"Gitter AH, Wullstein F, Fromm M, Schulzke JD. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 2001;121(6):1320\u20138. https:\/\/doi.org\/10.1053\/gast.2001.29694.","journal-title":"Gastroenterology"},{"issue":"2","key":"724_CR105","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.imr.2020.02.006","volume":"9","author":"HY Kim","year":"2020","unstructured":"Kim HY, Jeon H, Bae CH, Lee Y, Kim H, Kim S. Rumex japonicus Houtt. Alleviates dextran sulfate sodium-induced colitis by protecting tight junctions in mice. Integr Med Res. 2020;9(2):100398. https:\/\/doi.org\/10.1016\/j.imr.2020.02.006.","journal-title":"Integr Med Res"},{"issue":"2","key":"724_CR106","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/mi.2017.52","volume":"11","author":"SM Krug","year":"2018","unstructured":"Krug SM, Bojarski C, Fromm A, Lee IM, Dames P, Richter JF, et al. Tricellulin is regulated via interleukin-13-receptor \u03912, affects macromolecule uptake, and is decreased in ulcerative colitis. Mucosal Immunol. 2018;11(2):345\u201356. https:\/\/doi.org\/10.1038\/mi.2017.52.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"724_CR107","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12876-021-01723-7","volume":"31","author":"JE Hu","year":"2021","unstructured":"Hu JE, Wei\u00df F, Bojarski C, Branchi F, Schulzke JD, Fromm M, et al. Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis. BMC Gastroenterol. 2021;31(1):141. https:\/\/doi.org\/10.1186\/s12876-021-01723-7.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"724_CR108","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/MPG.0000000000001310","volume":"64","author":"S Guo","year":"2017","unstructured":"Guo S, Gillingham T, Guo Y, Meng D, Zhu W, Walker WA, et al. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus protect intestinal epithelial barrier function. J Pediatr Gastroenterol Nutr. 2017;64(3):404\u201312. https:\/\/doi.org\/10.1097\/MPG.0000000000001310.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"724_CR109","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","volume":"161","author":"WT Kuo","year":"2021","unstructured":"Kuo WT, Zuo L, Odenwald MA, Madha S, Singh G, Gurniak CB, et al. The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair. Gastroenterology. 2021;161(6):1924\u201339. https:\/\/doi.org\/10.1053\/j.gastro.2021.08.047.","journal-title":"Gastroenterology"},{"key":"724_CR110","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ebiom.2018.08.035","volume":"35","author":"M Zhou","year":"2018","unstructured":"Zhou M, Xu W, Wang J, Yan J, Shi Y, Zhang C, et al. Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-\u03baB pathway quenches intestinal inflammation and oxidative stress injury. EBioMedicine. 2018;35:345\u201360. https:\/\/doi.org\/10.1016\/j.ebiom.2018.08.035.","journal-title":"EBioMedicine"},{"issue":"10","key":"724_CR111","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/ibd\/izz149","volume":"18","author":"D Yao","year":"2019","unstructured":"Yao D, Dong M, Dai C, Wu S. Inflammation and inflammatory cytokine contribute to the initiation and development of ulcerative colitis and its associated cancer. Inflamm Bowel Dis. 2019;18(10):1595\u2013602. https:\/\/doi.org\/10.1093\/ibd\/izz149.","journal-title":"Inflamm Bowel Dis"},{"key":"724_CR112","doi-asserted-by":"publisher","unstructured":"Kawamoto A, Nagata S, Anzai S, Takahashi J, Kawai M, Hama M et al. Ubiquitin D is upregulated by synergy of Notch signalling and TNF-\u03b1 in the inflamed intestinal epithelia of IBD patients. J Crohns Colitis. 2019;30;13(4):495\u2013509. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy180","DOI":"10.1093\/ecco-jcc\/jjy180"},{"issue":"1","key":"724_CR113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","volume":"23","author":"E Martini","year":"2017","unstructured":"Martini E, Krug SM, Siegmund B, Neurath MF, Becker C. Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease. Cell Mol Gastroenterol Hepatol. 2017;23(1):33\u201346. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.03.007.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"724_CR114","doi-asserted-by":"publisher","first-page":"109505","DOI":"10.1016\/j.jnutbio.2023.109505","volume":"124","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu G, Fang J. Progress on the mechanisms of Lactobacillus plantarum to improve intestinal barrier function in ulcerative colitis. J Nutr Biochem. 2024;124:109505. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109505.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"724_CR115","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/aps.2017.185","volume":"39","author":"YX Yan","year":"2018","unstructured":"Yan YX, Shao MJ, Qi Q, Xu YS, Yang XQ, Zhu FH, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacol Sin. 2018;39(10):1633\u201344. https:\/\/doi.org\/10.1038\/aps.2017.185.","journal-title":"Acta Pharmacol Sin"},{"key":"724_CR116","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41385-022-00506","volume":"15","author":"J Ninnemann","year":"2022","unstructured":"Ninnemann J, Winsauer C, Bondareva M, K\u00fchl AA, Lozza L, Durek P, et al. TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability. Mucosal Immunol. 2022;15:698\u2013716. https:\/\/doi.org\/10.1038\/s41385-022-00506.","journal-title":"Mucosal Immunol"},{"key":"724_CR117","doi-asserted-by":"publisher","first-page":"104455","DOI":"10.1016\/j.phrs.2019.104455","volume":"148","author":"C Guo","year":"2019","unstructured":"Guo C, Wu K, Liang X, Liang Y, Li R. Infliximab clinically treating ulcerative colitis: A systematic review and meta-analysis. Pharmacol Res. 2019;148:104455. https:\/\/doi.org\/10.1016\/j.phrs.2019.104455.","journal-title":"Pharmacol Res"},{"key":"724_CR118","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1016\/S1590-8658(08)60530-7","volume":"2","author":"S Danese","year":"2008","unstructured":"Danese S. Mechanisms of action of Infliximab in inflammatory bowel disease: an anti-inflammatory multitasker. Dig Liver Dis 40 Suppl. 2008;2:S225\u20138. https:\/\/doi.org\/10.1016\/S1590-8658(08)60530-7.","journal-title":"Dig Liver Dis 40 Suppl"},{"key":"724_CR119","doi-asserted-by":"publisher","first-page":"700217","DOI":"10.3389\/fphar.2021.700217","volume":"19","author":"Z Chen","year":"2021","unstructured":"Chen Z, Yi L, Pan Y, Long X, Mu J, Yi R, Zhao X. Lactobacillus fermentum ZS40 ameliorates inflammation in mice with ulcerative colitis induced by dextran sulfate sodium. Front Pharmacol. 2021;19:12:700217. https:\/\/doi.org\/10.3389\/fphar.2021.700217.","journal-title":"Front Pharmacol"},{"key":"724_CR120","doi-asserted-by":"publisher","unstructured":"Chen X, Zhao X, Wang H, Yang Z, Li J, Suo H. Prevent Effects of Lactobacillus Fermentum HY01 on Dextran Sulfate Sodium-Induced Colitis in Mice. Nutrients. 2017 25;9(6):545. https:\/\/doi.org\/10.3390\/nu9060545","DOI":"10.3390\/nu9060545"},{"key":"724_CR121","doi-asserted-by":"publisher","unstructured":"Liu M, Zhang X, Hao Y, Ding J, Shen J, Xue Z et al. Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: in vivo and in vitro evidence. Food Funct 2019 20;10(2):1132\u201345. https:\/\/doi.org\/10.1039\/c8fo02301h","DOI":"10.1039\/c8fo02301h"},{"issue":"4","key":"724_CR122","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s10620-010-1384-1","volume":"56","author":"R D\u2019Inc\u00e0","year":"2011","unstructured":"D\u2019Inc\u00e0 R, Barollo M, Scarpa M, Grillo AR, Brun P, Vettorato MG, et al. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig Dis Sci. 2011;56(4):1178\u201387. https:\/\/doi.org\/10.1007\/s10620-010-1384-1.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"724_CR123","first-page":"1292","volume":"48","author":"H Wang","year":"2019","unstructured":"Wang H, Li S, Li H, Du F, Guan J, Wu Y. Mechanism of probiotic VSL#3 inhibiting NF-\u03baB and TNF-\u03b1 on colitis through TLR4-NF-\u03baB signal pathway. Iran J Public Health. 2019;48(7):1292\u2013300.","journal-title":"Iran J Public Health"},{"issue":"10","key":"724_CR124","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3748\/wjg.v10.i10.1521","volume":"15","author":"HH Cui","year":"2004","unstructured":"Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol. 2004;15(10):1521\u20135. https:\/\/doi.org\/10.3748\/wjg.v10.i10.1521.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"724_CR125","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4161\/gmic.25487","volume":"4","author":"D Groeger","year":"2013","unstructured":"Groeger D, O\u2019Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013;4(4):325\u201339. https:\/\/doi.org\/10.4161\/gmic.25487.","journal-title":"Gut Microbes"},{"key":"724_CR126","doi-asserted-by":"publisher","unstructured":"Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017;8416763. https:\/\/doi.org\/10.1155\/2017\/8416763.","DOI":"10.1155\/2017\/8416763"},{"key":"724_CR127","doi-asserted-by":"publisher","unstructured":"Canli \u00d6, Nicolas AM, Gupta J, Finkelmeier F, Goncharova O, Pesic M et al. Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis. Cancer Cell. 2017;11;32(6):869\u2013883.e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.11.004","DOI":"10.1016\/j.ccell.2017.11.004"},{"issue":"1","key":"724_CR128","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jss.2006.02.050","volume":"135","author":"T Yasuda","year":"2006","unstructured":"Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Nakajima T, et al. Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis. J Surg Res. 2006;135(1):18\u201326. https:\/\/doi.org\/10.1016\/j.jss.2006.02.050.","journal-title":"J Surg Res"},{"key":"724_CR129","doi-asserted-by":"publisher","unstructured":"Wittmann C, Chockley P, Singh SK, Pase L, Lieschke GJ, Grabher C. Hydrogen peroxide in inflammation: messenger, guide, and assassin. Adv Hematol. 2012:541471. https:\/\/doi.org\/10.1155\/2012\/541471","DOI":"10.1155\/2012\/541471"},{"key":"724_CR130","doi-asserted-by":"publisher","unstructured":"Pravda J. Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide. World J Gastroenterol. 2022;21;28(31):4263\u20134298. https:\/\/doi.org\/10.3748\/wjg.v28.i31.4263","DOI":"10.3748\/wjg.v28.i31.4263"},{"issue":"11","key":"724_CR131","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/antiox10111823","volume":"17","author":"SP Tsao","year":"2021","unstructured":"Tsao SP, Nurrahma BA, Kumar R, Wu CH, Yeh TH, Chiu CC, et al. Probiotic enhancement of antioxidant capacity and alterations of gut microbiota composition in 6-Hydroxydopamin-Induced Parkinson\u2019s disease rats. Antioxid (Basel). 2021;17(11):1823. https:\/\/doi.org\/10.3390\/antiox10111823.","journal-title":"Antioxid (Basel)"},{"issue":"15","key":"724_CR132","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.4161\/cc.10.15.16870","volume":"1","author":"MP Lisanti","year":"2011","unstructured":"Lisanti MP, Martinez-Outschoorn UE, Lin Z, Pavlides S, Whitaker-Menezes D, Pestell RG, et al. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis: the seed and soil also needs fertilizer. Cell Cycle. 2011;1(15):2440\u20139. https:\/\/doi.org\/10.4161\/cc.10.15.16870.","journal-title":"Cell Cycle"},{"issue":"3","key":"724_CR133","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/1871530319666181221150352","volume":"19","author":"A Ballini","year":"2019","unstructured":"Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, Topi S, et al. Probiotics efficacy on oxidative stress values in inflammatory bowel disease: A randomized Double-Blinded Placebo-Controlled pilot study. Endocr Metab Immune Disord Drug Targets. 2019;19(3):373\u201381. https:\/\/doi.org\/10.2174\/1871530319666181221150352.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"724_CR134","doi-asserted-by":"publisher","first-page":"1126579","DOI":"10.3389\/fnut.2023.1126579","volume":"20","author":"S Ashique","year":"2023","unstructured":"Ashique S, Mishra N, Garg A, Sibuh BZ, Taneja P, Rai G, et al. Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis. Front Nutr. 2023;20:10:1126579. https:\/\/doi.org\/10.3389\/fnut.2023.1126579.","journal-title":"Front Nutr"},{"key":"724_CR135","doi-asserted-by":"publisher","unstructured":"Guo P, Wang W, Xiang Q, Pan C, Qiu Y, Li T et al. Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis. Cell Host Microbe. 2024;11;32(9):1502\u20131518.e9. https:\/\/doi.org\/10.1016\/j.chom.2024.07.028","DOI":"10.1016\/j.chom.2024.07.028"},{"issue":"Pt 1","key":"724_CR136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1099\/jmm.0.47403-0","volume":"57","author":"A de Moreno de LeBlanc","year":"2008","unstructured":"de Moreno de LeBlanc A, LeBlanc JG, Perdig\u00f3n G, Miyoshi A, Langella P, Azevedo V, et al. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. J Med Microbiol. 2008;57(Pt 1):100\u20135. https:\/\/doi.org\/10.1099\/jmm.0.47403-0.","journal-title":"J Med Microbiol"},{"key":"724_CR137","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.lfs.2018.08.035","volume":"15","author":"KRM Barboza","year":"2018","unstructured":"Barboza KRM, Coco LZ, Alves GM, Peters B, Vasquez EC, Pereira TMC, et al. Gastroprotective effect of oral Kefir on indomethacin-induced acute gastric lesions in mice: impact on oxidative stress. Life Sci. 2018;15:209:370\u20136. https:\/\/doi.org\/10.1016\/j.lfs.2018.08.035.","journal-title":"Life Sci"},{"issue":"4","key":"724_CR138","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ibd\/izx100","volume":"19","author":"SR Knowles","year":"2018","unstructured":"Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of life in inflammatory bowel disease: A systematic review and Meta-analyses-Part I. Inflamm Bowel Dis. 2018;19(4):742\u201351. https:\/\/doi.org\/10.1093\/ibd\/izx100.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"724_CR139","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.dld.2021.03.002","volume":"53","author":"A Armuzzi","year":"2021","unstructured":"Armuzzi A, Liguori G. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: a narrative review. Dig Liver Dis. 2021;53(7):803\u20138. https:\/\/doi.org\/10.1016\/j.dld.2021.03.002.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"724_CR140","doi-asserted-by":"publisher","first-page":"7682","DOI":"10.1038\/s41598-022-11911-4","volume":"10","author":"A Abu Sneineh","year":"2022","unstructured":"Abu Sneineh A, Haj Ali S, Al-Masri A, Diab A, Aldweik F, Darweesh M, et al. Prevalence of anxiety and depressive symptoms in ulcerative colitis patients in Jordan and its relationship to patient-reported disease activity. Sci Rep. 2022;10(1):7682. https:\/\/doi.org\/10.1038\/s41598-022-11911-4.","journal-title":"Sci Rep"},{"issue":"4","key":"724_CR141","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5152\/tjg.2019.18356","volume":"30","author":"H Kamarl\u0131 Altun","year":"2019","unstructured":"Kamarl\u0131 Altun H, Akal Y\u0131ld\u0131z E, Ak\u0131n M. Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: A randomized placebo-controlled study. Turk J Gastroenterol. 2019;30(4):313\u201320. https:\/\/doi.org\/10.5152\/tjg.2019.18356.","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"724_CR142","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3904\/kjim.2021.458","volume":"37","author":"SK Park","year":"2022","unstructured":"Park SK, Kang SB, Kim S, Kim TO, Cha JM, Im JP, et al. Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis. Korean J Intern Med. 2022;37(5):949\u201357. https:\/\/doi.org\/10.3904\/kjim.2021.458.","journal-title":"Korean J Intern Med"},{"key":"724_CR143","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clnesp.2022.08.020","volume":"51","author":"LM Agraib","year":"2022","unstructured":"Agraib LM, Yamani MI, Tayyem R, Abu-Sneineh AT, Rayyan YM. Probiotic supplementation induces remission and changes in the Immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study. Clin Nutr ESPEN. 2022;51:83\u201391. https:\/\/doi.org\/10.1016\/j.clnesp.2022.08.020.","journal-title":"Clin Nutr ESPEN"},{"issue":"7","key":"724_CR144","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1007\/s00394-023-03207-8","volume":"62","author":"YM Rayyan","year":"2023","unstructured":"Rayyan YM, Agraib LM, Alkhatib B, Yamani MI, Abu-Sneineh AT, Tayyem RF. Does probiotic supplementation improve quality of life in mild-to-moderately active ulcerative colitis patients in Jordan? A secondary outcome of the randomized, double-blind, placebo-controlled study. Eur J Nutr. 2023;62(7):3069\u201377. https:\/\/doi.org\/10.1007\/s00394-023-03207-8.","journal-title":"Eur J Nutr"},{"issue":"6","key":"724_CR145","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.21037\/apm-21-1056","volume":"10","author":"Q Ou","year":"2021","unstructured":"Ou Q, Wang L, Wang K, Shao P. Effect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitis: a randomized trial. Ann Palliat Med. 2021;10(6):6606\u201316. https:\/\/doi.org\/10.21037\/apm-21-1056.","journal-title":"Ann Palliat Med"},{"key":"724_CR146","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.phanu.2019.100139","volume":"7","author":"MB van der Waal","year":"2019","unstructured":"van der Waal MB, Flach J, Browne PD, Besseling-van der Vaart I, Claassen E, van de Burgwal LH. Probiotics for improving quality of life in ulcerative colitis: exploring the patient perspective. PharmaNutrition. 2019;7:100139. https:\/\/doi.org\/10.1016\/j.phanu.2019.100139.","journal-title":"PharmaNutrition"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00724-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:11:23Z","timestamp":1747055483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00724-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00724-7","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, as this study is a review article and does not involve the collection of data from human or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}